{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699995389521152.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Fan Mo"}],"foaf:familyName":[{"@value":"Mo"}],"foaf:givenName":[{"@value":"Fan"}]}],"career":[{"institution":{"notation":[{"@value":"1The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699995389521152","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1158/1078-0432.ccr-14-1108"},{"@type":"URI","@value":"https://aacrjournals.org/clincancerres/article-pdf/21/7/1675/2030047/1675.pdf"},{"@type":"PMID","@value":"25687267"}],"notation":[{"@value":"Generation 2.5 Antisense Oligonucleotides Targeting the Androgen Receptor and Its Splice Variants Suppress Enzalutamide-Resistant Prostate Cancer Cell Growth"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1158/1078-0432.ccr-14-1108_ImYiipSRVJRvI7556KKUe5ajulr"},{"@type":"OPENAIRE","@value":"doi_dedup___::abb20401b22d809b403ec914a94cd469_ImYiipSRVJRvI7556KKUe5ajulr"}]}